LPGAT1 and metabolic dysfunction-associated steatotic liver disease: Loss of whole-body LPGAT1 protects mice from diet-induced obesity but leads to hepatopathy, insulin resistance, and nonalcoholic fatty liver diseases due to oxidative stress, mitochondrial DNA depletion, and mitochondrial dysfunction (38).